Antiepileptic drugs, pharmacopoeia:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
London [u.a.]
Springer
2011
|
| Schlagworte: | |
| Online-Zugang: | Inhaltstext 13 80 Inhaltsverzeichnis Inhaltsverzeichnis |
| Beschreibung: | Literaturverz. S. [93] - 103 |
| Beschreibung: | X, 108 S. 235 mm x 155 mm |
| ISBN: | 9780857290113 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV041902387 | ||
| 003 | DE-604 | ||
| 007 | t | ||
| 008 | 140611s2011 |||| 00||| eng d | ||
| 010 | |a 2010936356 | ||
| 015 | |a 10N37 |2 dnb | ||
| 016 | 7 | |a 1006693602 |2 DE-101 | |
| 020 | |a 9780857290113 |c PB. : EUR 26.70 (freier Pr.), sfr 36.00 (freier Pr.) |9 978-0-85729-011-3 | ||
| 035 | |a (OCoLC)838010130 | ||
| 035 | |a (DE-599)DNB1006693602 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RC374.C48 | |
| 082 | 0 | |a 616.853061 | |
| 084 | |a VS 7100 |0 (DE-625)147698:253 |2 rvk | ||
| 084 | |a 44.90 |2 bkl | ||
| 084 | |a 44.38 |2 bkl | ||
| 100 | 1 | |a Panayiotopoulos, Chrysostomos P. |e Verfasser |0 (DE-588)142013072 |4 aut | |
| 245 | 1 | 0 | |a Antiepileptic drugs, pharmacopoeia |c C. P. Panayiotopoulos |
| 264 | 1 | |a London [u.a.] |b Springer |c 2011 | |
| 300 | |a X, 108 S. |c 235 mm x 155 mm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturverz. S. [93] - 103 | ||
| 650 | 0 | 7 | |a Antiepileptikum |0 (DE-588)4142656-3 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Antiepileptikum |0 (DE-588)4142656-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 856 | 4 | |q text/html |u http://deposit.dnb.de/cgi-bin/dokserv?id=3534077&prov=M&dok_var=1&dok_ext=htm |3 Inhaltstext | |
| 856 | 4 | |u http://www.loc.gov/catdir/enhancements/fy1214/2010936356-b.html |3 13 | |
| 856 | 4 | |u http://www.loc.gov/catdir/enhancements/fy1214/2010936356-d.html |3 80 | |
| 856 | 4 | |u http://www.loc.gov/catdir/enhancements/fy1214/2010936356-t.html |3 Inhaltsverzeichnis | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027346100&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-027346100 | |
Datensatz im Suchindex
| _version_ | 1806328187059175424 |
|---|---|
| adam_text |
Titel: Antiepileptic drugs, pharmacopoeia
Autor: Panayiotopoulos, Chrysostomos P.
Jahr: 2011
Contents
Abbreviations.xi
Introduction.1
Recommended sources of information.2
Chapter 1
Acetazolamide.3
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Mechanism of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 2
Benzodiazepines.5
Main ADRs
Tolerance, dependence and withdrawal syndrome
Main mechanism of action
Chapter 3
Carbamazepine.7
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 4
Clobazam.13
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Main mechanism of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 5
Clonazepam.15
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Main mechanism of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 6
Eslicarbazepine acetate.17
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 7
Ethosuximide.21
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Other available succinimides
Chapter 8
Felbamate.23
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 9
Gabapentin.27
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 10
Lacosamide.31
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 11
Lamotrigine.35
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 12
Levetiracetam.43
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 13
Oxcarbazepine.49
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 14
Phenobarbital.53
Authorised indications
Current main applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Other available main barbiturate agents
Chapter 15
Phenytoin.55
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Disadvantages
Other available phenytoin-related agents
Chapter 16
Pregabalin.59
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 17
Rufinamide.63
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Mechanism of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 18
Stiripentol.67
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantage
Chapter 19
Sulthiame.69
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Mechanism of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 20
Tiagabine.71
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 21
Topiramate.73
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 22
Valproate.79
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Drug interactions
Main disadvantages
Chapter 23
Vigabatrin.85
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Main mechanisms of action
Pharmacokinetics
Drug interactions
Considerations in women
Main disadvantages
Chapter 24
Zonisamide.89
Authorised indications
Clinical applications
Dosage and titration
Main ADRs
Considerations in women
Main mechanisms of action
Pharmacokinetics
Interaction with other drugs
Main disadvantages
References.93 |
| any_adam_object | 1 |
| author | Panayiotopoulos, Chrysostomos P. |
| author_GND | (DE-588)142013072 |
| author_facet | Panayiotopoulos, Chrysostomos P. |
| author_role | aut |
| author_sort | Panayiotopoulos, Chrysostomos P. |
| author_variant | c p p cp cpp |
| building | Verbundindex |
| bvnumber | BV041902387 |
| callnumber-first | R - Medicine |
| callnumber-label | RC374 |
| callnumber-raw | RC374.C48 |
| callnumber-search | RC374.C48 |
| callnumber-sort | RC 3374 C48 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | VS 7100 |
| ctrlnum | (OCoLC)838010130 (DE-599)DNB1006693602 |
| dewey-full | 616.853061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.853061 |
| dewey-search | 616.853061 |
| dewey-sort | 3616.853061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV041902387</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">140611s2011 |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2010936356</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">10N37</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1006693602</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780857290113</subfield><subfield code="c">PB. : EUR 26.70 (freier Pr.), sfr 36.00 (freier Pr.)</subfield><subfield code="9">978-0-85729-011-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)838010130</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1006693602</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC374.C48</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.853061</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 7100</subfield><subfield code="0">(DE-625)147698:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Panayiotopoulos, Chrysostomos P.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)142013072</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antiepileptic drugs, pharmacopoeia</subfield><subfield code="c">C. P. Panayiotopoulos</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 108 S.</subfield><subfield code="c">235 mm x 155 mm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. [93] - 103</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antiepileptikum</subfield><subfield code="0">(DE-588)4142656-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antiepileptikum</subfield><subfield code="0">(DE-588)4142656-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="q">text/html</subfield><subfield code="u">http://deposit.dnb.de/cgi-bin/dokserv?id=3534077&prov=M&dok_var=1&dok_ext=htm</subfield><subfield code="3">Inhaltstext</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/enhancements/fy1214/2010936356-b.html</subfield><subfield code="3">13</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/enhancements/fy1214/2010936356-d.html</subfield><subfield code="3">80</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/enhancements/fy1214/2010936356-t.html</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027346100&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027346100</subfield></datafield></record></collection> |
| id | DE-604.BV041902387 |
| illustrated | Not Illustrated |
| indexdate | 2024-08-03T01:33:18Z |
| institution | BVB |
| isbn | 9780857290113 |
| language | English |
| lccn | 2010936356 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027346100 |
| oclc_num | 838010130 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | X, 108 S. 235 mm x 155 mm |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Springer |
| record_format | marc |
| spelling | Panayiotopoulos, Chrysostomos P. Verfasser (DE-588)142013072 aut Antiepileptic drugs, pharmacopoeia C. P. Panayiotopoulos London [u.a.] Springer 2011 X, 108 S. 235 mm x 155 mm txt rdacontent n rdamedia nc rdacarrier Literaturverz. S. [93] - 103 Antiepileptikum (DE-588)4142656-3 gnd rswk-swf Antiepileptikum (DE-588)4142656-3 s DE-604 text/html http://deposit.dnb.de/cgi-bin/dokserv?id=3534077&prov=M&dok_var=1&dok_ext=htm Inhaltstext http://www.loc.gov/catdir/enhancements/fy1214/2010936356-b.html 13 http://www.loc.gov/catdir/enhancements/fy1214/2010936356-d.html 80 http://www.loc.gov/catdir/enhancements/fy1214/2010936356-t.html Inhaltsverzeichnis HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027346100&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Panayiotopoulos, Chrysostomos P. Antiepileptic drugs, pharmacopoeia Antiepileptikum (DE-588)4142656-3 gnd |
| subject_GND | (DE-588)4142656-3 |
| title | Antiepileptic drugs, pharmacopoeia |
| title_auth | Antiepileptic drugs, pharmacopoeia |
| title_exact_search | Antiepileptic drugs, pharmacopoeia |
| title_full | Antiepileptic drugs, pharmacopoeia C. P. Panayiotopoulos |
| title_fullStr | Antiepileptic drugs, pharmacopoeia C. P. Panayiotopoulos |
| title_full_unstemmed | Antiepileptic drugs, pharmacopoeia C. P. Panayiotopoulos |
| title_short | Antiepileptic drugs, pharmacopoeia |
| title_sort | antiepileptic drugs pharmacopoeia |
| topic | Antiepileptikum (DE-588)4142656-3 gnd |
| topic_facet | Antiepileptikum |
| url | http://deposit.dnb.de/cgi-bin/dokserv?id=3534077&prov=M&dok_var=1&dok_ext=htm http://www.loc.gov/catdir/enhancements/fy1214/2010936356-b.html http://www.loc.gov/catdir/enhancements/fy1214/2010936356-d.html http://www.loc.gov/catdir/enhancements/fy1214/2010936356-t.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=027346100&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT panayiotopouloschrysostomosp antiepilepticdrugspharmacopoeia |